FindTrial
Sign In

THE USE OF DEXMEDETOMIDINE IN THE POSTOPERATIVE SEDATION OF HEAD AND NECK CANCER SURGERY

THE USE OF DEXMEDETOMIDINE IN THE POSTOPERATIVE SEDATION OF HEAD AND NECK CANCER SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-013123-33-FI
Enrollment
Unknown
Registered
2009-06-09
Start date
2009-08-26
Completion date
Unknown
Last updated
2013-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pään ja kaulan alueen syöpäpotilas MedDRA version: 9.1 Level: LLT Classification code 10024534 Term: Lip and/or oral cavity cancer NOS

Interventions

Trade Name: Precedex Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: PROPOFOL CAS Number: 2078-54-8 Pharmaceutical form of the placebo: Intravenous infusion Route of ad

Sponsors

Tays
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pään ja kaulan alueen syöpäpotilas Mikrovaskulaarisiirre, kyynärvarsikieleke Kirjallinen suostumus Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Kieltäytynyt tutkimuksesta Tiedossa oleva komplikaatioriski

Design outcomes

Primary

MeasureTime frame
Main Objective: Dexmedetomidiinin turvallisuuden osoittaminen mikrovaskulaarisiirteiden sedaatiossa;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026